Clinical

Dataset Information

0

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer


ABSTRACT: RATIONALE: PV701 may be able to kill tumor cells while leaving normal cells undamaged. PURPOSE: Phase I trial to study the effectiveness of PV701 in treating patients who have advanced or recurrent ovarian epithelial, fallopian tube, primary peritoneal, colorectal, or other cancer found primarily within the peritoneal cavity.

DISEASE(S): Cancer

PROVIDER: 2008913 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2016-12-15 | E-MTAB-5240 | biostudies-arrayexpress
2024-10-10 | GSE276935 | GEO
2019-12-31 | GSE131790 | GEO
| 2044746 | ecrin-mdr-crc
2026-05-27 | GSE330349 | GEO
2018-05-25 | GSE108084 | GEO
2016-08-24 | PXD003668 | Pride
| 2201578 | ecrin-mdr-crc
2013-11-25 | E-GEOD-37648 | biostudies-arrayexpress
2017-08-01 | E-MTAB-3706 | biostudies-arrayexpress